Connor, Clark & Lunn Investment Management »

Amicus Therapeutics shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.6M 111k 14.19
2023-09-30 $785k 65k 12.16
2023-06-30 $665k 53k 12.56
2023-03-31 $386k 35k 11.09
2022-06-30 $1.2M 111k 10.74
2020-12-31 $2.5M 108k 23.09
2018-03-31 $173k 12k 15.03
2017-12-31 $2.2M 156k 14.39
2017-09-30 $6.4M 427k 15.08
2017-06-30 $219k 22k 10.07
2015-12-31 $1.3M 129k 9.70
2015-09-30 $5.4M 383k 13.99
2015-06-30 $9.8M 692k 14.15
2015-03-31 $9.1M 837k 10.88
2014-12-31 $5.1M 526k 9.64
2014-09-30 $908k 137k 6.65
2014-03-31 $33k 15k 2.26